X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
angiogenesis (2) 2
cancer (2) 2
drug resistance (2) 2
extracellular matrix (2) 2
myeloid infiltration (2) 2
skin (2) 2
vascular biology & angiogenesis (2) 2
vascular normalization (2) 2
analysis (1) 1
angiogenesis; drug resistance; extracellular matrix; myeloid infiltration; vascular normalization; molecular medicine (1) 1
animals (1) 1
antineoplastic agents - administration & dosage (1) 1
development and progression (1) 1
digestive system diseases (1) 1
disease models, animal (1) 1
fibroblasts (1) 1
gluocose metabolism in cancer (1) 1
health aspects (1) 1
hypoxia (1) 1
index medicus (1) 1
indoles - administration & dosage (1) 1
kras (1) 1
metabolic adaptability in cancer (1) 1
metabolic rewiring (1) 1
mice (1) 1
mutant proteins - antagonists & inhibitors (1) 1
mutant proteins - genetics (1) 1
mutant proteins - metabolism (1) 1
mutation, missense (1) 1
neoplasms - pathology (1) 1
neoplasms - therapy (1) 1
nsclc (1) 1
pdac (1) 1
proto-oncogene proteins b-raf - antagonists & inhibitors (1) 1
proto-oncogene proteins b-raf - genetics (1) 1
proto-oncogene proteins b-raf - metabolism (1) 1
research article (1) 1
research articles (1) 1
sulfonamides - administration & dosage (1) 1
treatment outcome (1) 1
vascular endothelial growth factor (1) 1
vascular endothelial growth factor a - antagonists & inhibitors (1) 1
vascular endothelial growth factor a - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3394 - 3394
Journal Article
Frontiers in Oncology, 08/2019, Volume 9
Tumors driven by mutant KRAS are among the most aggressive and refractory to treatment. Unfortunately, despite the efforts, targeting alterations of this... 
metabolic rewiring | PDAC | metabolic adaptability in cancer | NSCLC | gluocose metabolism in cancer | KRAS
Journal Article
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 02/2017, Volume 9, Issue 2, pp. 219 - 237
The development of resistance remains a major obstacle to long‐term disease control in cancer patients treated with targeted therapies. In BRAF ‐mutant mouse... 
vascular normalization | drug resistance | myeloid infiltration | angiogenesis | extracellular matrix | Vascular Biology & Angiogenesis | Skin | Cancer
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 02/2017, Volume 9, Issue 2, pp. 219 - 237
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.